Table 2.

Predicted MoRFs regions in SARS-CoV-2 proteins

Proteins	MoRFchibi_web	ANCHOR	MoRFPred	DISOPRED3
Spike glycoprotein (S)	1265–1272	–	2–6, 819–823	1–10
Envelope (E)	46–75	–	–	26–30
Membrane (M)	187–221	–	214–222	117–132
Nucleocapsid (N)	1–20, 82–98, 102–118, 403–409	1–75, 104–113, 152–185, 201–236, 264–310, 347–361, 388–419	11–21, 48–58, 106–115, 218–228, 268–274, 354–358, 397–408	1–10,26–47,179–208,230–249,366–378,380–385,413–419
ORF3a	1–6, 261–268	–	7–12, 126, 230–233, 259–263	1–19
ORF3b	NA	–	NA	–
ORF6	14–21, 26–61	–	–	–
ORF7a	29–34, 39–51, 77–89	–	–	1–10
ORF7b	–	–	–	–
ORF8	1–5, 26–52, 69–91	–	–	1–10
ORF9b	3–29, 34–62, 79–84,	–	89–97	–
ORF10	3–7	–	–	–
ORF14	1–45	–	6–12	–
Nsp1	64–75, 93–97, 99–179	173–180	137–145, 172–179	1–6
Nsp2	1–7	–	–	–
Nsp3	–	105–171, 189–196	101–107, 184–194, 536–541, 980–984	–
Nsp4	–	–	495–500	1–25
Nsp5	3–8	–	–	–
Nsp6	–	–	–	1–19
Nsp7	1–30, 39–58, 65–83	–	–	–
Nsp8	181–185	–	89–93	–
Nsp9	40–44, 51–56, 62–77, 83–102	–	–	–
Nsp10	25–32, 91–99, 133–138	–	11–18	–
Nsp12	31–36	–	11–15	1–6
Nsp13	–	–	–	–
Nsp14	–	–	8–13, 441–445	–
Nsp15	–	–	9–13	–
Nsp16	–	–	151–156	–